You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

WT TP53

Showing 1 - 25 of 1,672
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer Trial (Navtemadlin, Navtemadlin Placebo)

Not yet recruiting
  • Endometrial Cancer
  • (no location specified)
Mar 21, 2023

AML, Adult Trial in Berne (HDM201, Midostaurin)

Terminated
  • AML, Adult
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Oct 3, 2022

Myeloid Leukemia, MDS Trial (IFN-?)

Not yet recruiting
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Nov 15, 2023

Relapsed or Refractory B-cell Lymphoma Trial in Shanghai (SR-GDP)

Not yet recruiting
  • Relapsed or Refractory B-cell Lymphoma
  • Shanghai, Shanhai, China
    Ruijin Hospital
Sep 29, 2023

Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)

Completed
  • Advanced Solid and Hematological TP53wt Tumors
  • Boston, Massachusetts
  • +14 more
May 20, 2021

Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • TP53-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Lymphoma, Mantle-Cell Trial in Shanghai (Zanubrutinib, Rituximab, Bendamustin)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Shanghai, Shanghai, China
    Ruijin Hospital
Nov 14, 2023

Aumolertinib, Anlotinib, TP53 Trial (Aumolertinib,Anlotinib)

Not yet recruiting
  • Aumolertinib
  • +4 more
  • (no location specified)
Mar 8, 2023

Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 25, 2023

Li-Fraumeni Syndrome, TP53 Gene Mutation, Hereditary Cancer Syndrome Trial in Boston (Data and Specimen Collection)

Recruiting
  • Li-Fraumeni Syndrome
  • +4 more
  • Data and Specimen Collection
  • Boston, Massachusetts
  • +2 more
Jan 23, 2023

NSCLC, NSCLC Trial in Guangzhou (Apatinib + Fluzoparib, Apatinib + Fluzoparib + Adebrelimab)

Not yet recruiting
  • NSCLC
  • Non-small Cell Lung Cancer
  • Apatinib + Fluzoparib
  • Apatinib + Fluzoparib + Adebrelimab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jun 27, 2023

NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +5 more
  • Autologous, engineered T Cells targeting TP53 R175H
  • Duarte, California
    City of Hope
May 17, 2023

Patients With Breast Cancer and Pathogenic Variants of TP53

Completed
  • Breast Cancer
  • +3 more
  • No intervention in this study
  • São Paulo, Brazil
    ICESP
Aug 5, 2022

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn
  • Advanced Solid Tumor
  • +9 more
  • (no location specified)
Oct 16, 2023

Non Small Cell Lung Cancer Trial in Italy (Osimertinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Ancona, Italy
  • +10 more
Mar 14, 2023

Advanced NSCLC Trial in Jinan (almonertinib)

Recruiting
  • Advanced Non-small Cell Lung Cancer
  • Jinan, Shandong, China
    Degan Lu
Sep 12, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Leukemia
  • (no location specified)
Nov 30, 2022

MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)

Terminated
  • MDS
  • Myelodysplastic Syndromes
  • APR-548 + Azacitidine
  • Tampa, Florida
  • +3 more
Jul 20, 2022

Tumors, Ovarian Cancer, Breast Cancer Trial in Houston (ZN-c3, Bevacizumab, Pembrolizumab)

Not yet recruiting
  • Tumors
  • +4 more
  • Houston, Texas
    MD Anderson Cancer Center
Jun 20, 2022

Clinical and Genetic Studies of Li-Fraumeni Syndrome

Recruiting
  • Li-Fraumeni Syndrome
  • +2 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    Non Small Cell Lung Cancer Trial in Guangzhou (SI-B001, AP or TP, Docetaxel)

    Recruiting
    • Non Small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center (SYSUCC)
    Mar 14, 2022

    Colorectal Cancer Trial in Salt Lake City (Cetuximab)

    Recruiting
    • Colorectal Cancer
    • Salt Lake City, Utah
    • +1 more
    May 3, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia, Relapsed, Adult Trial in Saint Louis (Decitabine, Bone marrow biopsy/aspirate,

    Terminated
    Has Results
    • Acute Myeloid Leukemia
    • Acute Myeloid Leukemia, Relapsed, Adult
    • Saint Louis, Missouri
      Washington University School of Medicine
    May 9, 2022

    NSCLC Trial in Guangzhou (Ensartinib, Bevacizumab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Aug 4, 2022

    Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500

    Recruiting
    • Prevention of Chemotherapy-induced Myelosuppression
    • ALRN-6924
    • TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
    • Tamarac, Florida
    • +14 more
    Jan 31, 2023